Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

This study is ongoing, but not recruiting participants.

Study NCT00081536 Information provided by Aronex Pharmaceuticals

First Received: April 15, 2004 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given